Vapen CBD Announces Exclusive THC-Free CBD Inhaler


VANCOUVER, July 10, 2019 /CNW/ – Vapen MJ Ventures (CSE: VAPN) (“Vapen MJ”) a fully integrated agricultural technology, services and property management company in the regulated cannabis industry, today announced the launch of their exclusive THC-Free CBD Inhalers.

The inhalers feature technology for a precisely metered dose of THC-free, pharmaceutical grade CBD. The line offers three flavors, Raw, Bubblegum and Strawberry, and is available in 1,000 milligram (mg) canisters that deliver 10 mg per puff for a total of 100 puffs per inhaler.

Vapen’s CBD inhaler technology is the best way to get a precisely measured and controlled dose of CBD. Vapen CBD inhalers are convenient and effective with a rapid absorption rate to deliver relief quickly. Each inhaler is produced by hand at Vapen’s U.S. facility to ensure accuracy and are third-party Lab Certified for purity and quality control.Â

“Vapen CBD makes premium pure, organic and bioavailable broad spectrum and isolate CBD products from our state-of-the-art facility in Phoenix, Arizona. We are passionate about delivering pure quality CBD products that make you feel better,” commented Thai Nguyen, Founder and Chief Executive Officer of Vapen MJ Ventures. “Expanding our product lines into the rapidly growing CBD market will strengthen the Vapen brand and expand our market reach to consumers seeking CBD benefits. This strategy aligns with our long-term growth plans to enhance our product offering, increase our brand awareness, and grow our distribution to drive shareholder value.”

The Vapen line of CBD Inhalers can be viewed and purchased on Vapen MJ’s website, www.VapenCBD.com/product-category/inhalers/. Vapen MJ also wholesales these products to retailers nationwide under the Vapen brand.

About Vapen MJ Ventures

Vapen MJ, through its wholly-owned subsidiaries, currently operates in the US as an agricultural technology, services and property management company utilizing a full vertical integration business model to oversee and execute all aspects of cultivation, extraction, manufacturing (THC and CBD cartridges, concentrates, edibles), retail dispensary, and wholesale distribution of high margin Cannabis THC and Hemp CBD products under the Vapen Brand. Vapen MJ expansion plans include partnering with cannabis license holders and hemp farms in multiple states within the US.Â

Forward Looking Statements

Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Vapen MJ’ periodic filings with Canadian securities regulators. When used in this news release, words such as “will, could, plan, estimate, expect, intend, may, potential, believe, should,” and similar expressions, are forward-looking statements.

Forward-looking statements may include, without limitation, statements related to future developments and the business and operations of Vapen MJ.

Although Vapen MJ has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; are engaged in activities currently considered illegal under U.S. Federal laws; change in laws; reliance on management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry and; regulatory or political change.

There can be no assurance that such information will prove to be accurate or that management’s expectations or estimates of future developments, circumstances or results will materialize. Because of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.

Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. Vapen MJ disclaims any intention or obligation to update or revise such information, except as required by applicable law, and Vapen MJ does not assume any liability for disclosure relating to any other company mentioned herein.

Bob Brilon, President and CFO, T: 602-620-9725, Investors@VapenMJ.com